6yzv - Revision history

OCA at 13:39, 24 January 2024

OCA — Wed, 24 Jan 2024 13:39:04 GMT

←Older revision		Revision as of 13:39, 24 January 2024
Line 1:		Line 1:

	==Closo-carborane ethyl-sulfonamide in complex with CA II==		==Closo-carborane ethyl-sulfonamide in complex with CA II==
-	<StructureSection load='6yzv' size='340' side='right'caption='[[6yzv]]' scene=''>	+	<StructureSection load='6yzv' size='340' side='right'caption='[[6yzv]], [[Resolution\|resolution]] 1.65Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6YZV OCA]. For a <b>guided tour on the structure components</b> use [~~http~~://proteopedia.org/fgij/fg.htm?mol=6YZV FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[6yzv]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6YZV OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=6YZV FirstGlance]. <br>
-	</td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[~~http~~://proteopedia.org/fgij/fg.htm?mol=6yzv FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6yzv OCA], [~~http~~://pdbe.org/6yzv PDBe], [~~http~~://www.rcsb.org/pdb/explore.do?structureId=6yzv RCSB], [~~http~~://www.ebi.ac.uk/pdbsum/6yzv PDBsum], [~~http~~://prosat.h-its.org/prosat/prosatexe?pdbcode=6yzv ProSAT]</span></td></tr>	+	</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models\|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution\|Resolution]] 1.65Å</td></tr>
		+	<tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=Q2Z:Carborane+ethyl-sulfonamide'>Q2Z</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene></td></tr>
		+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=6yzv FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6yzv OCA], [https://pdbe.org/6yzv PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=6yzv RCSB], [https://www.ebi.ac.uk/pdbsum/6yzv PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=6yzv ProSAT]</span></td></tr>
	</table>		</table>
		+	== Disease ==
		+	[https://www.uniprot.org/uniprot/CAH2_HUMAN CAH2_HUMAN] Defects in CA2 are the cause of osteopetrosis autosomal recessive type 3 (OPTB3) [MIM:[https://omim.org/entry/259730 259730]; also known as osteopetrosis with renal tubular acidosis, carbonic anhydrase II deficiency syndrome, Guibaud-Vainsel syndrome or marble brain disease. Osteopetrosis is a rare genetic disease characterized by abnormally dense bone, due to defective resorption of immature bone. The disorder occurs in two forms: a severe autosomal recessive form occurring in utero, infancy, or childhood, and a benign autosomal dominant form occurring in adolescence or adulthood. Autosomal recessive osteopetrosis is usually associated with normal or elevated amount of non-functional osteoclasts. OPTB3 is associated with renal tubular acidosis, cerebral calcification (marble brain disease) and in some cases with mental retardation.<ref>PMID:1928091</ref> <ref>PMID:1542674</ref> <ref>PMID:8834238</ref> <ref>PMID:9143915</ref> <ref>PMID:15300855</ref>
		+	== Function ==
		+	[https://www.uniprot.org/uniprot/CAH2_HUMAN CAH2_HUMAN] Essential for bone resorption and osteoclast differentiation (By similarity). Reversible hydration of carbon dioxide. Can hydrate cyanamide to urea. Involved in the regulation of fluid secretion into the anterior chamber of the eye.<ref>PMID:10550681</ref> <ref>PMID:11831900</ref>
		+	<div style="background-color:#fffaf0;">
		+	== Publication Abstract from PubMed ==
		+	Human carbonic anhydrase IX (CA IX), a protein specifically expressed on the surface of solid tumour cells, represents a validated target both for anticancer therapy and diagnostics. We recently identified sulfonamide dicarbaboranes as promising inhibitors of CA IX with favourable activities both in vitro and in vivo. To explain their selectivity and potency, we performed detailed X-ray structural analysis of their interactions within the active sites of CA IX and CA II. Series of compounds bearing various aliphatic linkers between the dicarbaborane cluster and sulfonamide group were examined. Preferential binding towards the hydrophobic part of the active site cavity was observed. Selectivity towards CA IX lies in the shape complementarity of the dicarbaborane cluster with a specific CA IX hydrophobic patch containing V131 residue. The bulky side chain of F131 residue in CA II alters the shape of the catalytic cavity, disrupting favourable interactions of the spherical dicarbaborane cluster.
		+
		+	The structural basis for the selectivity of sulfonamido dicarbaboranes toward cancer-associated carbonic anhydrase IX.,Kugler M, Holub J, Brynda J, Pospisilova K, Anwar SE, Bavol D, Havranek M, Kral V, Fabry M, Gruner B, Rezacova P J Enzyme Inhib Med Chem. 2020 Dec;35(1):1800-1810. doi:, 10.1080/14756366.2020.1816996. PMID:32962427<ref>PMID:32962427</ref>
		+
		+	From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>
		+	</div>
		+	<div class="pdbe-citations 6yzv" style="background-color:#fffaf0;"></div>
		+
		+	==See Also==
		+	*[[Carbonic anhydrase 3D structures\|Carbonic anhydrase 3D structures]]
		+	== References ==
		+	<references/>
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
		+	[[Category: Homo sapiens]]
	[[Category: Large Structures]]		[[Category: Large Structures]]
	[[Category: Brynda J]]		[[Category: Brynda J]]

OCA at 20:35, 28 October 2020

OCA — Wed, 28 Oct 2020 20:35:26 GMT

←Older revision		Revision as of 20:35, 28 October 2020
Line 1:		Line 1:
-	'''Unreleased structure'''

-	~~The entry~~ 6yzv ~~is ON HOLD until Paper Publication~~	+	==Closo-carborane ethyl-sulfonamide in complex with CA II==
-		+	<StructureSection load='6yzv' size='340' side='right'caption='[[6yzv]]' scene=''>
-	~~Authors~~: ~~Kugler~~, M., ~~Brynda~~, J., ~~Pospisilova, K~~., ~~Rezacova, P~~.	+	== Structural highlights ==
-		+	<table><tr><td colspan='2'>Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6YZV OCA]. For a <b>guided tour on the structure components</b> use [http://proteopedia.org/fgij/fg.htm?mol=6YZV FirstGlance]. <br>
-	~~Description: Closo-carborane ethyl-sulfonamide in complex with CA II~~	+	</td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://proteopedia.org/fgij/fg.htm?mol=6yzv FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6yzv OCA], [http://pdbe.org/6yzv PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6yzv RCSB], [http://www.ebi.ac.uk/pdbsum/6yzv PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6yzv ProSAT]</span></td></tr>
-	[[Category: ~~Unreleased~~ Structures]]	+	</table>
-	[[Category: Brynda, J]]	+	__TOC__
-	[[Category: ~~Pospisilova, K~~]]	+	</StructureSection>
-	[[Category: ~~Rezacova, P~~]]	+	[[Category: Large Structures]]
-	[[Category: ~~Kugler, M~~]]	+	[[Category: Brynda J]]
		+	[[Category: Kugler M]]
		+	[[Category: Pospisilova K]]
		+	[[Category: Rezacova P]]

OCA at 09:27, 29 July 2020

OCA — Wed, 29 Jul 2020 09:27:18 GMT

←Older revision		Revision as of 09:27, 29 July 2020
Line 1:		Line 1:
	'''Unreleased structure'''		'''Unreleased structure'''

-	The entry 6yzv is ON HOLD	+	The entry 6yzv is ON HOLD until Paper Publication

	Authors: Kugler, M., Brynda, J., Pospisilova, K., Rezacova, P.		Authors: Kugler, M., Brynda, J., Pospisilova, K., Rezacova, P.
Line 7:		Line 7:
	Description: Closo-carborane ethyl-sulfonamide in complex with CA II		Description: Closo-carborane ethyl-sulfonamide in complex with CA II
	[[Category: Unreleased Structures]]		[[Category: Unreleased Structures]]
		+	[[Category: Brynda, J]]
	[[Category: Pospisilova, K]]		[[Category: Pospisilova, K]]
	[[Category: Rezacova, P]]		[[Category: Rezacova, P]]
-	[[Category: Brynda, J]]
	[[Category: Kugler, M]]		[[Category: Kugler, M]]

OCA at 04:28, 20 May 2020

OCA — Wed, 20 May 2020 04:28:42 GMT

←Older revision		Revision as of 04:28, 20 May 2020
Line 5:		Line 5:
	Authors: Kugler, M., Brynda, J., Pospisilova, K., Rezacova, P.		Authors: Kugler, M., Brynda, J., Pospisilova, K., Rezacova, P.

-	Description: ~~Carborane~~ ethyl-sulfonamide in complex with CA II ~~CAII_CB23~~	+	Description: Closo-carborane ethyl-sulfonamide in complex with CA II
	[[Category: Unreleased Structures]]		[[Category: Unreleased Structures]]
	[[Category: Pospisilova, K]]		[[Category: Pospisilova, K]]
-	[[Category: Brynda, J]]
	[[Category: Rezacova, P]]		[[Category: Rezacova, P]]
		+	[[Category: Brynda, J]]
	[[Category: Kugler, M]]		[[Category: Kugler, M]]

OCA: Protected "6yzv" [edit=sysop:move=sysop]

OCA — Wed, 13 May 2020 04:19:59 GMT

Protected "6yzv" [edit=sysop:move=sysop]

←Older revision

Revision as of 04:19, 13 May 2020

OCA: New page: '''Unreleased structure''' The entry 6yzv is ON HOLD Authors: Kugler, M., Brynda, J., Pospisilova, K., Rezacova, P. Description: Carborane ethyl-sulfonamide in complex with CA II CAII_...

OCA — Wed, 13 May 2020 04:19:58 GMT

New page: '''Unreleased structure''' The entry 6yzv is ON HOLD Authors: Kugler, M., Brynda, J., Pospisilova, K., Rezacova, P. Description: Carborane ethyl-sulfonamide in complex with CA II CAII_...

New page

'''Unreleased structure'''

The entry 6yzv is ON HOLD

Authors: Kugler, M., Brynda, J., Pospisilova, K., Rezacova, P.

Description: Carborane ethyl-sulfonamide in complex with CA II CAII_CB23
[[Category: Unreleased Structures]]
[[Category: Pospisilova, K]]
[[Category: Brynda, J]]
[[Category: Rezacova, P]]
[[Category: Kugler, M]]